Literature DB >> 24855099

Use of multiple imputation to correct for bias in lung cancer incidence trends by histologic subtype.

Mandi Yu1, Eric J Feuer2, Kathleen A Cronin2, Neil E Caporaso3.   

Abstract

BACKGROUND: Over the past several decades, advances in lung cancer research and practice have led to refinements of histologic diagnosis of lung cancer. The differential use and subsequent alterations of nonspecific morphology codes, however, may have caused artifactual fluctuations in the incidence rates for histologic subtypes, thus biasing temporal trends.
METHODS: We developed a multiple imputation (MI) method to correct lung cancer incidence for nonspecific histology using data from the Surveillance, Epidemiology, and End Results Program during 1975 to 2010.
RESULTS: For adenocarcinoma in men and squamous in both genders, the change to an increasing trend around 2005, after more than 10 years of decreasing incidence, is apparently an artifact of the changes in histopathology practice and coding system. After imputation, the rates remained decreasing for adenocarcinoma and squamous in men, and became constant for squamous in women.
CONCLUSIONS: As molecular features of distinct histologies are increasingly identified by new technologies, accurate histologic distinctions are becoming increasingly relevant to more effective "targeted" therapies, and therefore, are important to track in patients. However, without incorporating the coding changes, the incidence trends estimated for histologic subtypes could be misleading. IMPACT: The MI approach provides a valuable tool for bridging the different histology definitions, thus permitting meaningful inferences about the long-term trends of lung cancer by histologic subtype. ©2014 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2014        PMID: 24855099      PMCID: PMC4119525          DOI: 10.1158/1055-9965.EPI-14-0130

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  23 in total

1.  Permutation tests for joinpoint regression with applications to cancer rates.

Authors:  H J Kim; M P Fay; E J Feuer; D N Midthune
Journal:  Stat Med       Date:  2000-02-15       Impact factor: 2.373

2.  From single-race reporting to multiple-race reporting: using imputation methods to bridge the transition.

Authors:  Nathaniel Schenker; Jennifer D Parker
Journal:  Stat Med       Date:  2003-05-15       Impact factor: 2.373

3.  Multiple-imputation for measurement-error correction.

Authors:  Stephen R Cole; Haitao Chu; Sander Greenland
Journal:  Int J Epidemiol       Date:  2006-05-18       Impact factor: 7.196

4.  Imputation of missing values is superior to complete case analysis and the missing-indicator method in multivariable diagnostic research: a clinical example.

Authors:  Geert J M G van der Heijden; A Rogier T Donders; Theo Stijnen; Karel G M Moons
Journal:  J Clin Epidemiol       Date:  2006-07-11       Impact factor: 6.437

Review 5.  A critical look at methods for handling missing covariates in epidemiologic regression analyses.

Authors:  S Greenland; W D Finkle
Journal:  Am J Epidemiol       Date:  1995-12-15       Impact factor: 4.897

6.  Histological classification of lung cancer.

Authors:  D Lamb
Journal:  Thorax       Date:  1984-03       Impact factor: 9.139

7.  EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy.

Authors:  J Guillermo Paez; Pasi A Jänne; Jeffrey C Lee; Sean Tracy; Heidi Greulich; Stacey Gabriel; Paula Herman; Frederic J Kaye; Neal Lindeman; Titus J Boggon; Katsuhiko Naoki; Hidefumi Sasaki; Yoshitaka Fujii; Michael J Eck; William R Sellers; Bruce E Johnson; Matthew Meyerson
Journal:  Science       Date:  2004-04-29       Impact factor: 47.728

8.  Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib.

Authors:  Thomas J Lynch; Daphne W Bell; Raffaella Sordella; Sarada Gurubhagavatula; Ross A Okimoto; Brian W Brannigan; Patricia L Harris; Sara M Haserlat; Jeffrey G Supko; Frank G Haluska; David N Louis; David C Christiani; Jeff Settleman; Daniel A Haber
Journal:  N Engl J Med       Date:  2004-04-29       Impact factor: 91.245

9.  Cigarette smoking and changes in the histopathology of lung cancer.

Authors:  M J Thun; C A Lally; J T Flannery; E E Calle; W D Flanders; C W Heath
Journal:  J Natl Cancer Inst       Date:  1997-11-05       Impact factor: 13.506

10.  Lung cancer.

Authors:  W D Travis; L B Travis; S S Devesa
Journal:  Cancer       Date:  1995-01-01       Impact factor: 6.860

View more
  13 in total

1.  Privacy-Preserving Methods for Vertically Partitioned Incomplete Data.

Authors:  Yi Deng; Xiaoqian Jiang; Qi Long
Journal:  AMIA Annu Symp Proc       Date:  2021-01-25

2.  Cancer Incidence and Survival Trends by Subtype Using Data from the Surveillance Epidemiology and End Results Program, 1992-2013.

Authors:  Anne-Michelle Noone; Kathleen A Cronin; Sean F Altekruse; Nadia Howlader; Denise R Lewis; Valentina I Petkov; Lynne Penberthy
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-12-12       Impact factor: 4.254

3.  US lung cancer trends by histologic type.

Authors:  Manali I Patel; Iona Cheng; Scarlett Lin Gomez
Journal:  Cancer       Date:  2014-12-02       Impact factor: 6.921

4.  Incidence trends of lung cancer by immigration status among Chinese Americans.

Authors:  Scarlett Lin Gomez; Juan Yang; Shih-Wen Lin; Margaret McCusker; Alan Sandler; Iona Cheng; Heather A Wakelee; Manali Patel; Christina A Clarke
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-05-19       Impact factor: 4.090

5.  Lung cancer incidence trends by histology type among Asian American, Native Hawaiian, and Pacific Islander populations in the United States, 1990-2010.

Authors:  Iona Cheng; Gem M Le; Anne-Michelle Noone; Kathleen Gali; Manali Patel; Robert W Haile; Heather A Wakelee; Scarlett L Gomez
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-11       Impact factor: 4.090

6.  Associations of DNMT3B -149C>T and -2437T>A polymorphisms and lung cancer risk in Chinese population.

Authors:  Min Gao; Daqiang He; Fanji Meng; Jianing Li; Yan Shen
Journal:  World J Surg Oncol       Date:  2016-11-22       Impact factor: 2.754

7.  Recent Spatiotemporal Patterns of US Lung Cancer by Histologic Type.

Authors:  Denise Riedel Lewis; Linda W Pickle; Li Zhu
Journal:  Front Public Health       Date:  2017-05-19

8.  Lung Cancer Survival Among Chinese Americans, 2000 to 2010.

Authors:  Scarlett Lin Gomez; Juan Yang; Shih-Wen Lin; Margaret McCusker; Alan Sandler; Manali Patel; Iona Cheng; Heather A Wakelee; Christina A Clarke
Journal:  J Glob Oncol       Date:  2016-01-20

9.  Temporal Trends and Geographic Patterns of Lung Cancer Incidence by Histology in Thailand, 1990 to 2014.

Authors:  Joanne T Chang; Jihyoun Jeon; Hutcha Sriplung; Seesai Yeesoonsang; Surichai Bilheem; Laura Rozek; Imjai Chitapanarux; Donsuk Pongnikorn; Karnchana Daoprasert; Patravoot Vatanasapt; Krittika Suwanrungruang; Rafael Meza
Journal:  J Glob Oncol       Date:  2018-08

10.  Divergent trends in lung cancer incidence by gender, age and histological type in Estonia: a nationwide population-based study.

Authors:  Tiiu Aareleid; Mari-Liis Zimmermann; Aleksei Baburin; Kaire Innos
Journal:  BMC Cancer       Date:  2017-08-30       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.